Skip to main content
. 2017 Nov 6;12:8115–8127. doi: 10.2147/IJN.S139436

Figure 3.

Figure 3

In vitro release profiles of PUE and SCU from PUE-SCU CLN formulations (n=3).

Abbreviations: PUE, puerarin; SCU, scutellarin; CLN, cationic lipid nanoparticle.